Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-11 4:07 pm Sale | 2025-06-06 | 13G | Venus Concept Inc. VERO | Orca Capital AG | 101,748 4.900% | -6,932 (-6.38%) | Filing History |
| 2025-06-11 4:05 pm Purchase | 2025-06-06 | 13G | Venus Concept Inc. VERO | Orca Capital AG | 108,680 5.900% | 108,680 (New Position) | Filing History |
| 2025-05-09 4:36 pm Sale | 2025-05-07 | 13G | Pasithea Therapeutics Corp. KTTA | Orca Capital AG | 362,857 4.900% | -8,285 (-2.23%) | Filing History |
| 2025-05-09 4:31 pm Purchase | 2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA | Orca Capital AG | 371,142 5.700% | 371,142 (New Position) | Filing History |
| 2025-04-23 4:30 pm Sale | 2025-04-22 | 13G | Can-Fite BioPharma Ltd. CANF | Orca Capital AG | 157,382,700 4.100% | -217,617,300 (-58.03%) | Filing History |
| 2025-04-16 4:30 pm Purchase | 2025-04-14 | 13G | Can-Fite BioPharma Ltd. CANF | Orca Capital AG | 375,000,000 9.700% | 375,000,000 (New Position) | Filing History |
| 2025-04-14 4:30 pm Sale | 2025-04-11 | 13G | Venus Concept Inc. VERO | Orca Capital AG | 0 0.000% | -83,429 (Position Closed) | Filing History |
| 2025-04-11 4:30 pm Purchase | 2025-04-09 | 13G | Venus Concept Inc. VERO | Orca Capital AG | 83,429 8.000% | 83,429 (New Position) | Filing History |
| 2025-03-17 5:53 pm Sale | 2025-03-14 | 13G | Dogwood Therapeutics, Inc. DWTX | Orca Capital AG | 69,821 3.700% | -45,969 (-39.70%) | Filing History |
| 2025-03-17 5:49 pm Purchase | 2025-03-12 | 13G | Dogwood Therapeutics, Inc. DWTX | Orca Capital AG | 115,790 6.100% | 115,790 (New Position) | Filing History |
| 2025-02-18 4:15 pm Sale | 2025-02-14 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Orca Capital AG | 120,012 4.500% | -97,380 (-44.79%) | Filing History |
| 2025-02-13 4:48 pm Purchase | 2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Orca Capital AG | 217,392 8.100% | 217,392 (New Position) | Filing History |
| 2025-02-04 7:51 pm Sale | 2025-01-31 | 13G | Enveric Biosciences, Inc. ENVB | Orca Capital AG | 97,019 4.900% | -69,648 (-41.79%) | Filing History |
| 2025-02-04 7:47 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Orca Capital AG | 166,667 8.700% | 166,667 (New Position) | Filing History |
| 2025-02-04 7:42 pm Sale | 2025-01-31 | 13G | SuperCom Ltd. SPCB | Orca Capital AG | 124,583 3.600% | -148,144 (-54.32%) | Filing History |
| 2025-02-03 5:21 pm Sale | 2025-01-31 | 13G | Singularity Future Technology Ltd. SGLY | Orca Capital AG | 0 0.000% | -233,334 (Position Closed) | Filing History |
| 2025-01-31 2:12 pm Purchase | 2025-01-30 | 13G | SuperCom Ltd. SPCB | Orca Capital AG | 272,727 7.800% | 272,727 (New Position) | Filing History |
| 2025-01-28 5:03 pm Purchase | 2025-01-24 | 13G | Singularity Future Technology Ltd. SGLY | Orca Capital AG | 233,334 5.600% | 233,334 (New Position) | Filing History |
| 2025-01-23 3:45 pm Purchase | 2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO | Orca Capital AG | 514,965 9.900% | 514,965 (New Position) | Filing History |
| 2025-01-21 06:16 am Sale | 2025-01-13 | 13G | Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT | Orca Capital AG | 0 0.000% | -92,000 (Position Closed) | Filing History |